COMPASS Pathways CMPS Stock
$11.05
-1.162790%
Add to favorites
SECTOR
INDUSTRY
COUNTRY
Exchange
Market Cap
$1.53B
LOW - HIGH [24H]
$10.94
-
$11.36
VOLUME [24H]
$1.52M
P/E Ratio
0
Earnings per share
-$3.76
ISIN
US20451W1018
COMPASS Pathways Price Chart
COMPASS Pathways CMPS Financial and Trading Overview
| COMPASS Pathways stock price | 11.05 USD |
| Previous Close | 11.63 USD |
| Open | 11.45 USD |
| Bid | 8.28 USD x 200 |
| Ask | 14.14 USD x 200 |
| Day's Range | 11.03 - 11.52 USD |
| 52 Week Range | 4.88 - 15.87 USD |
| Volume | 1.16M USD |
| Avg. Volume | 2.71M USD |
| Market Cap | 1.55B USD |
| Beta (5Y Monthly) | 2.564 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -3.76 USD |
| Forward Dividend & Yield | N/A (0%) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 23.75 USD |
CMPS Valuation Measures
| Enterprise Value | 1.17B USD |
| Trailing P/E | N/A |
| Forward P/E | -7.800018 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 17.945425 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | -6.302 |
Trading Information
COMPASS Pathways Stock Price History
| Beta (5Y Monthly) | 2.564 |
| 52-Week Change | 70.94% |
| S&P500 52-Week Change | 10.88% |
| 52 Week High | 15.87 USD |
| 52 Week Low | 4.88 USD |
| 50-Day Moving Average | 13.11 USD |
| 200-Day Moving Average | 10.29 USD |
CMPS Share Statistics
| Avg. Volume (3 month) | 2.71M USD |
| Avg. Daily Volume (10-Days) | 2.51M USD |
| Shares Outstanding | 138.48M |
| Float | 106.97M |
| Short Ratio | 6.08 |
| % Held by Insiders | 7.62% |
| % Held by Institutions | 69.18% |
| Shares Short | 17.03M |
| Short % of Float | 12.46% |
| Short % of Shares Outstanding | 12.30% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | N/A |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2025 |
| Most Recent Quarter (mrq) | June 30, 2026 |
| Next Fiscal Year End | December 31, 2026 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -29.083% |
| Return on Equity (ttm) | -319.065% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | -185563008 USD |
| Net Income Avi to Common (ttm) | -394187008 USD |
| Diluted EPS (ttm) | -3.76 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 433.3M USD |
| Total Cash Per Share (mrq) | 3.13 USD |
| Total Debt (mrq) | 54.63M USD |
| Total Debt/Equity (mrq) | 64.62 USD |
| Current Ratio (mrq) | 1.295 |
| Book Value Per Share (mrq) | 0.623 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -161136000 USD |
| Levered Free Cash Flow (ttm) | 249.95M USD |
Profile of COMPASS Pathways
| Country | United States |
| State | N/A |
| City | London |
| Address | 33 Broadwick Street |
| ZIP | W1F 0DQ |
| Phone | 44 716 6766461 |
| Website | https://compasspathways.com |
| Industry | Medical Care Facilities |
| Sector(s) | Healthcare |
| Full Time Employees | 156 |
COMPASS Pathways plc operates as a biotechnology company that focuses on mental health in the United Kingdom and the United States. The company develops COMP360, a psilocybin therapy, which is in Phase III clinical trial for the treatment of treatment-resistant depression; and is in Phase II clinical trial for treating post-traumatic stress disorder and anorexia nervosa. The company was formerly known as COMPASS Rx Limited and changed its name to COMPASS Pathways plc in August 2020. The company was incorporated in 2020 and is headquartered in London, the United Kingdom.
Q&A For COMPASS Pathways Stock
What is a current CMPS stock price?
COMPASS Pathways CMPS stock price today per share is 11.05 USD.
How to purchase COMPASS Pathways stock?
You can buy CMPS shares on the Tech Market Large exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for COMPASS Pathways?
The stock symbol or ticker of COMPASS Pathways is CMPS.
Which industry does the COMPASS Pathways company belong to?
The COMPASS Pathways industry is Medical Care Facilities.
How many shares does COMPASS Pathways have in circulation?
The max supply of COMPASS Pathways shares is 138.48M.
What is COMPASS Pathways Price to Earnings Ratio (PE Ratio)?
COMPASS Pathways PE Ratio is now.
What was COMPASS Pathways earnings per share over the trailing 12 months (TTM)?
COMPASS Pathways EPS is -3.76 USD over the trailing 12 months.
Which sector does the COMPASS Pathways company belong to?
The COMPASS Pathways sector is Healthcare.
COMPASS Pathways CMPS included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
|
|
{{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
US Tech Composite
IXIC
US
|
26169.38 USD — |
+0.82
|
6.51B USD — | 25986.56 USD — | 26306.82 USD — | — - | 6.51B USD — |
|
Stlmt ID US Tech Biotechnology
NBX
US
|
4000.62 USD — |
-1.26
|
— — | 3927.42 USD — | 4148.65 USD — | — - | — — |
|
US Tech Global Select Market Com
NQGS
US
|
12891.98 USD — |
+0.84
|
— — | 12800.44 USD — | 12959.92 USD — | — - | — — |
|
US Tech Biotechnology
NBI
US
|
7019.19 USD — |
+0.38
|
— — | 6971.86 USD — | 7062.01 USD — | — - | — — |
|
US Tech Health Care
IXHC
US
|
1333.33 USD — |
+0.41
|
— — | 1325.41 USD — | 1341.7 USD — | — - | — — |
- {{ link.label }} {{link}}
